Postingan

CareLineLive secures £1.2 million funding to support digitalisation and innovation within the homecare sector

Led by Haatch Ventures, the investment will support CareLineLive’s international expansion and grow headcount London, UK; 19th April 2021: CareLineLive, the homecare management software that increases efficiency, capacity, compliance and communication between managers and carers by digitising their workflows, today announced that it has fundraised £1.2 million to support its national and international expansion. The investment, led by Haatch Ventures, will see CareLineLive’s headcount continue to grow, with a 30% headcount increase already seen since September 2020. Alongside this, the investment will accelerate CareLineLive’s expansion into international markets, with 10% of its customers currently outside the UK, including recent client wins in Australia, Malta and Zimbabwe. Josh Hough, Founder and MD, CareLineLive, commented: “Homecare is in need of modernisation globally and technology is helping to revolutionise the way it is provided for agencies, carers and their clients. Rec
Posting Komentar
Baca selengkapnya

Grünenthal acquires Mestex AG and its Phase-III-ready investigational medicine MTX-071 for the treatment of pain associated with osteoarthritis of the knee 

With the acquisition of Mestex AG, Grünenthal secures global rights for an attractive late-stage asset that could offer an innovative therapy option for millions of patients affected by pain related to osteoarthritis of the knee. MTX-071 (resiniferatoxin) is a highly potent Transient Receptor Potential Vanilloid 1 (TRPV1) agonist. Its administration can reversibly defunctionalise TRPV1-expressing nociceptors. This can result in long lasting pain relief. Aachen, Germany, 12 April 2021 – Today, Grünenthal has announced the acquisition of Mestex AG through the takeover of all of its shares and options. Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with osteoarthritis of the knee. The investigational medicine is currently concluding Phase II of clinical development and is about to enter Phase III. Initial data showed a long-lasting and significant analgesic e
Posting Komentar
Baca selengkapnya

REaD Group and Marie Curie Celebrate Award Success with Multi Award-Winning Insight Project

But the real winner is dataLondon, 5 August 2019 – Marketing data and insight agency REaD Group has further cemented its success in data-driven and insight marketing after winning a number of awards at two separate industry events, and being shortlisted for a further three categories in a third.Alongside Marie Curie, REaD Group was named as winner of the Best Use of Insight Award at the IoF National Fundraising Awards on 2nd July for the Big SHIFT project. The National Fundraising Awards celebrate the very best in fundraising and are a unique opportunity to showcase excellence in the charity fundraising sector.The award follows swiftly on the heels of REaD’s win at the Insight in Fundraising Awards in June. Together with Marie Curie, REaD took home the Most Powerful Insight using Data Analysis award. The awards recognise the best work, innovation and inspirational stories of individuals working in data, analysis and insight contributing to fundraising practices.REaD was also shortliste
Posting Komentar
Baca selengkapnya

Trialbee are Looking for Volunteers with Eczema for Clinical Trial

Is eczema a part of your life? Volunteers needed for clinical trialTrialbee has now made it possible for about 80 candidates with eczema to volunteer in a medical research study around North Yorkshire & Sheffield. The screening period starts mid- September but pre sign-up is already possible. Get started.How can I participate?To be eligible, you must be:18 years of age or olderDiagnosed with moderate to severe eczemaAdvised not to apply creams or moisturizers for dry skinPurpose of the study: The purpose of this study is to explore the efficacy and safety of an investigational treatment for everyone with moderate to severe eczema (atopic dermatitis). Clinical and non-clinical studies have found there is a realistic expectation that this treatment will provide meaningful therapeutic benefit in eczema. Sign UpAbout TrialbeeTrialbee facilitates patient recruitment communication and cooperation between the various players involved in the entire clinical trial process. The company is sp
Posting Komentar
Baca selengkapnya

University of New England Delivers Cutting Edge Virtual Reality Nursing Education with Oxford Medical Simulation

Virtual Reality (VR) simulation allows nursing students at the University of New England to practice caring for acutely ill virtual patients within an immersive, realistic setting. Training healthcare professionals using VR serves to support clinical skill development, thereby advancing safe, high quality patient care. BOSTON, MA, Nov. 6th, 2019 - The University of New England (UNE) is working with Oxford Medical Simulation (OMS) to deliver state-of-the-art virtual reality software to transform nursing education. The immersive virtual reality platform supports nursing students at the UNE School of Nursing and Population Health in providing simulated patient care to advance clinical decision making and communication skills with other health care providers. This training allows nursing students to practice in true-to-life virtual scenarios without posing risk or harm to patients and families.The technology is developed by Oxford Medical Simulation, an award-winning VR simulation company
Posting Komentar
Baca selengkapnya

Fresenius Kabi starts United for Clinical Nutrition initiative in Europe with first-of-its-kind clinical study assessing critically ill patients in 11 European countries

BAD HOMBURG, GERMANY – [November 18, 2019] The first patients are about to be enrolled in the EuroPN survey, a clinical study that will assess the nutritional balance and focus on functional outcomes of critically ill patients in about 100 hospitals across 11 European countries. The survey is an important scientific project by United for Clinical Nutrition (UFCN), a global initiative that strives to fight hospital malnutrition and its detrimental effects on patient outcomes. Healthcare professionals in about 100 hospitals from Austria, Belgium, Czech Republic, France, Germany, Hungary, Italy, Poland, Spain, Sweden and the United Kingdom will collect data on the nutritional status of their patients as well as caloric and protein intake during ICU stay. Caloric and protein balance will be related to clinical outcomes, with a focus on measures of physical function. The collected data will provide insights into the current practice of clinical nutrition in critically ill patients and
Posting Komentar
Baca selengkapnya

e-days partners with Doctor Care Anywhere so businesses can direct employees straight to virtual GP services

- New partnership first of its kind to link absence management systems to on-demand medical healthcare and advice- As Coronavirus spreads, Doctor Care Anywhere fielding hundreds of calls per day, relieving pressure on NHS London, UK: 17th March 2020: Employees can now access virtual GP services via their company’s absence management system, following a partnership between e-days, the leader in global absence intelligence, and Doctor Care Anywhere. The announcement sees e-days, the global absence management and intelligence platform, offer integrated real-time wellbeing resources to workers. For the first time ever, companies will be able to link employee absence data and employee wellbeing by providing targeted services and resources to get them well more quickly. This comes at a particularly poignant time as concerns grow for the spread of COVID-19 in the UK. The solution is designed to give employees 24/7 access to GP bookings, for video or telephone-based consultations, at t
Posting Komentar
Baca selengkapnya